Solid Biosciences Inc. reclassified director Ilan Ganot from Class III to Class I to balance board membership, with his new term expiring at the 2028 Annual Meeting and stockholders to vote on ratification at the 2026 meeting.
Key takeaways
Director Ilan Ganot resigned from the Class III board seat effective April 10, 2026, to facilitate board rebalancing.
The board simultaneously decreased Class III directors to three, increased Class I directors to three, and appointed Ganot to fill a Class I vacancy.
Ganot's new Class I term will expire at the Company's 2028 Annual Meeting of Stockholders, altering his election timeline.
The Company will seek stockholder ratification of Ganot's Class I appointment on an advisory basis at the 2026 Annual Meeting.
No changes were made to Ganot's compensation arrangements, and no compensation is due for this board reclassification.